Abstract
Leprosy is one of the oldest and most intriguing human diseases. Evidence of leprosy is found in some of the earliest records of human history, such as in bible scriptures, as well as from human skeletons dating as far back as 2000 before Christ (1) . The most common complications of leprosy include loss of sensation, atrophy, paresis, and muscle paralysis. If these conditions are not adequately treated during their early manifestations, they may progress to permanent sequelae and/ or disabilities (2) . Since 2001, a three-grade classification system has been used to grade impairments of eyes, hands, and feet (3) . Grade 0 involves no leprosy-related impairments; grade 1 involves loss or decrease in sensation; and grade 2 involves the eyes (lagophthalmos, ectropion, trichiasis, central corneal opacity, or visual acuity lower than 0.1 or an inability to count the examiner's fingers at a distance of 6m); hands (trophic and/ or traumatic lesions, clawed hands, bone reabsorption, or wrist drop); and feet (trophic and/or traumatic lesions, clawed feet, bone reabsorption, foot drop, or ankle contracture) (3) . These symptoms impair several activities, including activities of daily living (ADL).
The ADL comprise typical tasks required for self-care and self-maintenance, such as hygiene, bathing, and feeding (4) .
Impaired occupational performance may trigger a process that frequently influences people's biopsychosocial context, impairing self-esteem and the sense of independence (5) . The rehabilitation process for disabled people includes the therapeutic use of assistive technology (AT) devices to compensate patients' impairments and deficits, aiming to increase, maintain, or improve functional skills. This process increases patients' sense of satisfaction and life purpose (6) . In general, AT is able to improve several areas of human performance, ranging from simple daily tasks, including feeding and writing, to complex tasks, such as driving (7) . AT adaptations are customized devices that are prescribed, and that aim to enable functional recovery and to stimulate independence (5) . AT adaptations enable different levels of improvement of functional independence, dependent on the devices, procedures, and the patient's remaining functional potential (8) . Using AT for leprosy patients aims to facilitate the performance of ADL by promoting more comfort, stability, and functionality when using the impaired limb (9) .
In this study, we aimed to verify the benefits of AT adaptations for leprosy patients with grade 2 disabilities. In addition, we aimed to show the influence of AT as a therapeutic procedure, both for this study's participants and for the population of interest. This research focused on the influence of AT adaptations on feeding among leprosy patients with grade 2 disabilities, specifically focusing on adaptations to compensate the participants' leprosy-related disabilities. Thus, it comprises an analysis of the participants' ADL performances before and after using AT devices, aiming to verify possible changes in performance and satisfaction.
Research risks included device-related aspects, such as possible allergic reactions or contamination; improper use, pain, discomfort and/or maladjustment; and changes in household dynamics during the research period. We planned to minimize these risks by using minimally privacy-invasive methods, paying close attention to biomechanical, anthropometric, sensory, and motor principles, as well as using reliable materials that were comfortable, durable, lightweight, and affordable. Research benefits comprised improvements in the participants' quality of life, functionality, and social and occupational participation. In addition, this research might demonstrate the effectiveness of using AT as a therapeutic procedure for the broader population of interest.
Five individuals met the inclusion and exclusion criteria and participated in this research. Inclusion criteria were a diagnosis of leprosy, a grade 2 disability, difficulty performing at least two ADL, and being 18-65 years old. Exclusion criteria comprised diagnoses other than leprosy, other disability grades, no difficulty performing ADL, being younger than 18 years or older than 65 years old, and having neurodegenerative comorbidities or a mental illness or disorder.
The first step included participant assessment and inclusion in the study, which encompassed a clinical assessment, signing the informed consent form, and initial assessment using the Canadian Occupational Performance Measure (COPM). We selected the COPM for this research, since it is a validated and reliable instrument that has been successfully used in different populations and settings. The administration of this instrument comprises a semi-structured interview that provides data regarding which activities have more importance or meaning for the participants, and how much difficulty they experience when performing each activity. The COPM aims to measure changes in the clients' perceptions of their occupational performance over time, as well as changes in their level of satisfaction with their performance. These data help the examiner to set goals, plan treatment, and measure the clients' progress (10) (11) . The participants can use the COPM to report which activities they need and/or wish to perform; individuals can report which activities they are expected to perform but are either unable to or are able to but are unsatisfied with their actual performance. Each participant rates the importance of different activities using a 10-point rating scale, which ranges from 1 (not important at all) to 10 (extremely important). Based on these data, the individual selects up to five highly important activities and rates them according to both performance and satisfaction using a 10-point scale ranging from 1 (unable to perform the activity/ very dissatisfied) to 10 (perfectly able to perform the activity/ extremely satisfied). The total score is obtained by summing the scores for performance and satisfaction. Comparing the scores of the initial and final assessment provides a measure of progress. The authors who created the measure highlighted that even a 2-point change is clinically significant (10) .
The second step comprised prescribing and fitting of the AT adaptive devices, as well as ADL training while wearing the devices. The training included ten 45-minute therapeutic sessions. The feeding device was made of ethyl vinyl acetate, contact adhesive, and Velcro®. The device was attached to the spoon/knife/fork handle, aiming to compensate deficits in grasp and holding patterns. We were very thorough when choosing the materials and designing the devices, which were planned and built based on each participant's anthropometric profile and biotype. The therapeutic use of an AT device encompasses the participant's adjustment and adaptation to a new situation (12) . Adaptation is intrinsically related to occupations, in which use of the device enhances independence in ADL (13) .
The third step encompassed the final assessment using the COPM and the data analysis. We performed a quantitative statistical analysis of the data provided by the COPM. The analysis of effect size regarding the use of AT devices was based on data resulting from standardized and non-standardized protocols, as well as observation records. We stored the data in Microsoft Excel files and used BioEstat 5.0 software for statistical analysis. We used descriptive and inferential methods to analyze the effect of using AT devices on performance and satisfaction of the sample comprising leprosy patients with grade 2 disabilities (n = 5). Quantitative variables were presented as measures of central tendency and variability. Normality was assessed using the Shapiro-Wilk test. Qualitative variables were presented using proportional distributions. We used the Wilcoxon test to compare the scores on the COPM before and after the exposure to use of the AT device, since the variables were not normally distributed. Alpha was set at 0.05 for rejection of the null hypothesis. The data collection and analysis were performed in the Assistive Technology Laboratory at Pará State University's Center of Biological and Health Sciences in 2014. Based on the initial data collection, including clinical assessment and the COPM, we found that all participants experienced feedingrelated difficulty, particularly difficulty holding eating utensils. Figure 1 shows the participants' COPM scores for performance before and after using AT devices while eating. Based on this graph, we observed significant changes in the pre-and post-intervention scores. Figure 2 shows the COPM satisfaction scores before and after using the adaptive device to perform feeding. We observed significant changes in this item. Table 1 shows the results of the feeding assessment using the COPM in terms of performance and satisfaction scores. We found a statistically significant (p < 0.05) change in the post-intervention or With AT device performance scores (median = 10.0) compared to the pre-intervention or "Without AT device" scores (median = 3.0), which denotes a 7-point average performance improvement. Similarly, the post-intervention satisfaction scores (median=10.0) showed a statistically significant (p < 0.05) change compared to the pre-intervention scores (median = 3), which denotes a 7-point average satisfaction improvement.
Patients with leprosy usually need to overcome various levels of life changes resulting from disease-related disabilities. Physical disabilities include decrease in sensation and the motor potential of their limbs. Social disabilities comprise loss of social, family, and work relationships, as well as socialization potential. Psychological disabilities encompass loss of a sense of self-assurance in addition to emotional coping and positive self-concept potentials (14) . Assistive technology devices can be part of facilitated environments, since they enable maximization of remaining potentials and occupational resignification. In this context, AT aims to minimize a patient's functional disabilities by using therapeutic resources that assist the performance of daily activities, improve functional performance, equalize opportunities, and increase independence (15) .
This research used the COPM to verify significant quantitative improvements in participants' performance and satisfaction in undertaking an ADL, eating, after using AT devices; the scores for these outcomes were greatly improved. Consequently, the intervention was highly effective, since it enhanced the performance of impaired daily activities, enabled occupational resignification, and restored previous routines that were hindered by functional losses. In addition, a comparison between the pre-and post-intervention scores showed that the participants demonstrated more confidence, motivation, comfort, selfassurance, and enthusiasm with their new ADL-related perspectives.
Assistive technology is a field of knowledge that aims to promote social participation and empowerment, as well as the re-establishment of routines with significant improvement in performance. Thus, it aims to provide an effective therapy, which enhances self-confidence, self-assurance, autonomy, and independence. The use of AT adaptive devices in this research strongly influenced the occupational performance and satisfaction of leprosy patients with grade 2 disabilities in terms of feeding activities. These two outcomes suggest that AT devices might be effective therapeutic tools for leprosy patients.
This study has some limitations, such as the small number of participants and the focus on one specific type of ADL. Thus, the study requires replication using a larger number of participants aiming to enhance external validity. In addition, considering the level of impairment of grade 2 leprosy-related disabilities, it would be interesting to perform studies with other types of ADL, aiming to expand the knowledge regarding the use of AT devices for leprosy patients.
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